Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A Phase 1 Study of CD19 Specific Chimeric Antigen Receptor T-cell for Therapy of persistent and Relapsed B-cell leukaemia and Lymphoma Post Allogeneic Stem Cell Transplantation (The CARTELL Study)
Protocol ID
CARTELL
Disease (Sub Disease)
Leukaemia
Diagnosis Stage
Relapse/refractory
Location
NSW
Sponsor
Western Sydney Local Health District, Westmead Hospital
Trial Status
Open
Sites
The Children's Hospital at Westmead
Study Type
Treatment
Phase
Phase 1
Age Eligibility
no limits
ANZCTR
ACTRN12617001579381
Back to Registry
Study Title A Phase 1 Study of CD19 Specific Chimeric Antigen Receptor T-cell for Therapy of persistent and Relapsed B-cell leukaemia and Lymphoma Post Allogeneic Stem Cell Transplantation (The CARTELL Study)
Protocol ID CARTELL
Disease (Sub Disease) Leukaemia
Diagnosis Stage Relapse/refractory
Location NSW
Sponsor Western Sydney Local Health District, Westmead Hospital
Links https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373934&isReview=true
Trial Status Open
Trial Open Date 19/11/2017
Sites The Children's Hospital at Westmead
Study Type Treatment
Phase Phase 1
Age Eligibility no limits
ANZCTR ACTRN12617001579381